81
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Comorbidity and survival of Danish prostate cancer patients from 2000–2011: a population-based cohort study

, , , , &
Pages 47-55 | Published online: 01 Nov 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

L. McWilliams, C. Farrell, G. Grande, J. Keady, C. Swarbrick & J. Yorke. (2018) A systematic review of the prevalence of comorbid cancer and dementia and its implications for cancer-related care. Aging & Mental Health 22:10, pages 1254-1271.
Read now
Marie Hjälm-Eriksson, Anders Ullén, Hemming Johansson, Seymoure Levitt, Sten Nilsson & Karl-Mikael Kälkner. (2017) Comorbidity as a predictor of overall survival in prostate cancer patients treated with external beam radiotherapy combined with HDR brachytherapy boosts. Acta Oncologica 56:1, pages 21-26.
Read now
Anne Gulbech Ording, Erzsébet Horváth-Puhó, Timothy L. Lash, Vera Ehrenstein, Michael Borre, Mogens Vyberg & Henrik Toft Sørensen. (2016) Does comorbidity interact with prostate cancer to increase mortality? A Danish cohort study of 45 326 prostate cancer patients diagnosed during 1995–2011. Acta Oncologica 55:5, pages 611-618.
Read now

Articles from other publishers (7)

Flávio de Macêdo Evangelista, Francine Nesello Melanda, Viviane Cardozo Modesto, Mariana Rosa Soares, Marco Aurélio Bertúlio das Neves, Bárbara da Silva Nalin de Souza, Neuciani Ferreira da Silva e Sousa, Noemi Dreyer Galvão & Amanda Cristina de Souza Andrade. (2022) Incidência, mortalidade e sobrevida do câncer de próstata em dois municípios com alto índice de desenvolvimento humano de Mato Grosso, Brasil. Revista Brasileira de Epidemiologia 25:suppl 1.
Crossref
Flávio de Macêdo Evangelista, Francine Nesello Melanda, Viviane Cardozo Modesto, Mariana Rosa Soares, Marco Aurélio Bertúlio das Neves, Bárbara da Silva Nalin de Souza, Neuciani Ferreira da Silva e Sousa, Noemi Dreyer Galvão & Amanda Cristina de Souza Andrade. (2022) Incidence, mortality and survival of prostate cancer in two municipalities with a high human development index in Mato Grosso, Brazil. Revista Brasileira de Epidemiologia 25:suppl 1.
Crossref
Mathias Raedkjaer, Katja Maretty-Kongstad, Thomas Baad-Hansen, Peter Holmberg Jørgensen, Akmal Safwat, Peter Vedsted, Michael Mørk Petersen, Thea Hovgaard, Tine Nymark & Johnny Keller. (2018) The impact of comorbidity on mortality in Danish sarcoma patients from 2000-2013: A nationwide population-based multicentre study. PLOS ONE 13:6, pages e0198933.
Crossref
Sonia Faria Mendes Braga, Mirian Carvalho de Souza, Raphael Romie de Oliveira, Eli Iola Gurgel Andrade, Francisco de Assis Acurcio & Mariangela Leal Cherchiglia. (2017) Patient survival and risk of death after prostate cancer treatment in the Brazilian Unified Health System. Revista de Saúde Pública 51:0.
Crossref
Anne G. Ording, Erzsébet Horváth-Puhó, Timothy L. Lash, Vera Ehrenstein, Michael Borre, Mogens Vyberg & Henrik T. Sørensen. (2015) Prostate cancer, comorbidity, and the risk of venous thromboembolism: A cohort study of 44,035 Danish prostate cancer patients, 1995-2011. Cancer 121:20, pages 3692-3699.
Crossref
András Inotai, Zsolt Abonyi-Tóth, György Rokszin & Zoltán Vokó. (2015) Prognosis, Cost, and Occurrence of Colorectal, Lung, Breast, and Prostate Cancer in Hungary. Value in Health Regional Issues 7, pages 1-8.
Crossref
L S G Østgård, J M Nørgaard, H Sengeløv, M Severinsen, L S Friis, C W Marcher, I H Dufva & M Nørgaard. (2014) Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study. Leukemia 29:3, pages 548-555.
Crossref